Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Links shared publicly online about this topic.

1,378
total visits

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.

View full resource at news-medical.net

Tags: Pharma, Novartis, Teva Pharmaceutical Industries, Litigation